NEK2 plays an active role in Tumorigenesis and Tumor Microenvironment in Non-Small Cell Lung Cancer

Bai, Rui; Yuan, Cheng; Sun, Wenjie; Zhang, Jianguo; Luo, Yuan; Gao, Yanping; Li, Yangyi; Gong, Yan; Xie, Conghua

doi:10.7150/ijbs.59019



Theranostics

International Journal of Medical Sciences

Nanotheranostics

Journal of Cancer

Journal of Genomics

Global reach, higher impact

Full Text | PDF

Int J Biol Sci 2021; 17(8):1995-2008. doi:10.7150/ijbs.59019 This issue Cite

Research Paper

NEK2 plays an active role in Tumorigenesis and Tumor Microenvironment in Non-Small Cell Lung Cancer

Rui Bai^1*, Cheng Yuan^1*, Wenjie Sun¹, Jianguo Zhang¹, Yuan Luo¹, Yanping Gao¹, Yangyi Li¹, Yan Gong^2,3✉, Conghua Xie^1,4,5✉

1. Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan, University, Wuhan, Hubei 430071, China.
2. Department of Biological Repositories, Zhongnan Hospital of Wuhan, University, Wuhan, Hubei 430071, China.
3. Tumor Precision Diagnosis and Treatment Technology and Translational Medicine Hubei Engineering Research Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China.
4. Hubei Key Laboratory of Tumour Biological Behaviors, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China.
5. Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China.
*These authors contributed equally to this work.

Citation:

Bai R, Yuan C, Sun W, Zhang J, Luo Y, Gao Y, Li Y, Gong Y, Xie C. NEK2 plays an active role in Tumorigenesis and Tumor Microenvironment in Non-Small Cell Lung Cancer. Int J Biol Sci 2021; 17(8):1995-2008. doi:10.7150/ijbs.59019. https://www.ijbs.com/v17p1995.htm

Other styles

Abstract

Abnormal expression and dysfunction of Never-in-mitosis-A-related kinase 2 (NEK2) result in tumorigenesis. High levels of NEK2 are related to malignant progression, drug resistance, and poor prognosis. However, the relationship between NEK2 levels and the occurrence of non-small cell lung cancer (NSCLC) remains unknown. This study aimed to explore the impacts of NEK2 on the oncogenesis of NSCLC and the tumor microenvironment. Downregulation of NEK2 inhibited A549 and H1299 cell proliferation, migration, and invasion, blocking cell cycle at the G0/G1 phase. Loss of NEK2 inhibited the release of IL-10 from tumor cells, M2-like polarization of macrophages, angiogenesis, and vascular endothelial cell migration. Furthermore, NEK2 deficiency inhibited tumor growth in vivo. Taken together, NEK2 knockdown inhibited the occurrence and development of NSCLC, M2 polarization of macrophages, and angiogenesis. The abnormal expression of NEK2 might not only indicate tumor progression and patient prognosis but also serve as a potential molecular therapeutic target with great development prospects.

Keywords: NEK2, NSCLC, tumorigenesis, Wnt/β-catenin, tumor microenvironment

Citation styles

APA

Bai, R., Yuan, C., Sun, W., Zhang, J., Luo, Y., Gao, Y., Li, Y., Gong, Y., Xie, C. (2021). NEK2 plays an active role in Tumorigenesis and Tumor Microenvironment in Non-Small Cell Lung Cancer. International Journal of Biological Sciences, 17(8), 1995-2008. https://doi.org/10.7150/ijbs.59019.

ACS

Bai, R.; Yuan, C.; Sun, W.; Zhang, J.; Luo, Y.; Gao, Y.; Li, Y.; Gong, Y.; Xie, C. NEK2 plays an active role in Tumorigenesis and Tumor Microenvironment in Non-Small Cell Lung Cancer. Int. J. Biol. Sci. 2021, 17 (8), 1995-2008. DOI: 10.7150/ijbs.59019.

NLM

CSE

Bai R, Yuan C, Sun W, Zhang J, Luo Y, Gao Y, Li Y, Gong Y, Xie C. 2021. NEK2 plays an active role in Tumorigenesis and Tumor Microenvironment in Non-Small Cell Lung Cancer. Int J Biol Sci. 17(8):1995-2008.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.